HELE Faces Securities Class Action on Top of Tariff Woes

What happened

Helen of Troy now faces a securities fraud class action covering purchases between April 24, 2024 and October 8, 2025, adding legal overhang to an already challenged turnaround. The lawsuit follows a period when the company repeatedly cut guidance and recorded $806.7M in impairments as tariffs disrupted orders and forced stop-shipments to enforce price increases. The new legal risk compounds existing concerns: revenue disruption from retailer direct-import cancellations, a leveraged balance sheet with net debt/EBITDA of 3.49x, and tightening covenant headroom as the maximum leverage ratio steps down. While the lawsuit's merits are untested, it creates potential discovery costs and management distraction during a critical window when stop-shipments must end and sourcing migration must deliver measurable results. The market already prices in a distressed turnaround at ~$17.72, but litigation introduces a binary outcome that could delay or impair the recovery thesis.

Implication

The class action does not change the fundamental operating challenges—tariff mitigation, retailer behavior, and covenant compliance—but it injects a new source of uncertainty. Investors should monitor filings for allegations of misleading statements about tariff exposure and guidance. The base case of a multi-quarter repair remains intact, but the likelihood of a bear-case scenario rises if the lawsuit forces settlements or diverts management attention. Our WAIT rating is reinforced; we would need to see stop-shipments end in FY26 Q4 and the lawsuit dismissed or settled on favorable terms before considering an entry near our attractive entry of $15.

Thesis delta

The addition of a securities fraud lawsuit raises the risk of unforeseen liabilities and management distraction, lowering the probability of a smooth turnaround. Previously, the thesis hinged on operational execution; now legal overhang creates a second layer of downside that could delay the recovery timeline. The lawsuit does not alter the fundamental operational milestones, but it reduces the margin of safety further, making the stock untouchable until both operational and legal risks clear.